Connect
MJA
MJA

Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue

Ali Khavandi, John Whitaker and Hanney Gonna
Med J Aust 2008; 189 (9) || doi: 10.5694/j.1326-5377.2008.tb02168.x
Published online: 3 November 2008

To the Editor: Serotonin toxicity is an under-recognised, potentially fatal syndrome that is becoming more common as the use of serotonergic drugs increases.1 We report a case of serotonin toxicity following the concomitant use of the antidepressant citalopram and methylene blue.

The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.


  • Southmead Hospital, Bristol, United Kingdom.



  • 1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352: 1112-1120.
  • 2. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol 2007; 152: 946-951.
  • 3. Kartha SS, Chacko CE, Bumpous JM, et al. Toxic metabolic encephaolopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg 2006; 135: 765-768.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.